Ono Pharma突破性科学倡议奖的申请流程 在申请Ono Pharma突破性科学倡议奖的过程中,申请者不仅需要准备详尽的材料,还需面对各种挑战和复杂的评审流程。首先,除了研究计划和支持信,个人简历的准备也至关重要。申请者的简历应突出其学术成就、研究经历以及与申请项目相关的技能,这样可以帮助评审委员会更好地理解申请者的背...
Ono Pharma Terminates Licensing Agreement with Eli Lily.Provides information on the termination of the worldwide exclusive license agreement of Ono Pharmaceutical Co. Ltd. with Eli Lilly for the development, manufacturing and marketing of Sivelestat, a novel therapeutic agent for acute lung injury. ...
doi:doi:US5024999 AFujikawa; Yoshihiro (Funabashi, JP), Suzuki; Mikio (Funabashi, JP), Iwasaki; Hiroshi (Funabashi, JP)USUS5024999 Apr 13, 1989 Jun 18, 1991 Nissan Chemical Industries Ltd. Pyrazolopyridine type mevalonolactones useful as pharmaeuticals...
Pharmacognostical Studies on the Chinese Crude Drug "Xuelianhua" and Related Ethonomedicines (Part 4) On Botanical Origins of the Chinese "Xuelianhua" and ... In previous papers, we anatomically confirmed the botanical origins of the Chinese "Xuelianhua" and related crude drugs. They were ...
Ono Pharmaceutical Co., Ltd announced that it has entered into a license agreement with Ionis Pharmaceuticals, Inc. for sapablursen, an investigational RNA-targeted medicine for the treatment of polycythemia vera (PV) - Ionis.com / ONO-Pharma.com
Image credit: shutterstock Japanese firm Ono Pharmaceutical has received the approval of Opdivo (nivolumab) Intravenous Infusion, a human anti-human PD-1 monoclonal antibody, in Taiwan from the Taiwan Food and Drug Administration (TFDA), for neoadjuvant treatment of adult pati...
Onyx Signs Deal with Ono Pharma - Analyst BlogZacks Equity Research